25-Year study of lung fibrosis following carmustine therapy for brain tumor in childhood [10]

Chest

Volumn 126, Issue 3, 2004, Pages 1007-

  Lohani, Sudhir ^a,b   O'Driscoll, B Ronan ^a   Woodcock, Ashley A ^a  

^a Hope Hospital ^*

^b HOPE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CARMUSTINE;

BRAIN TUMOR; CHEMOTHERAPY; CHILDHOOD; FOLLOW UP; HIGH RISK POPULATION; HUMAN; LETTER; LUNG FIBROSIS; LUNG FUNCTION TEST; PRIORITY JOURNAL; RADIODIAGNOSIS;

EID: 19444379330     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.126.3.1007     Document Type: Letter

References (2)

1. O'Driscoll BR, Kalra S, Gattamaneni HR, et al. Late carmustine lung fibrosis: age at treatment may influence severity and survival. Chest 1995; 107:1355-1357
2. O'Driscoll BR, Hasleton PS, Taylor PM, et al. Active lung fibrosis up to 17 years after chemotherapy with carmustine (BCNU) in childhood. N Engl J Med 1990; 323:378-382